Recent Posts
- Breakthrough Cited for Recurrent Glioblastoma (CME/CE)
- Boosting Boron’s Expanding Use In Medicine
- Lipid Involved With Gene Regulation Uncovered
- Unlicensed Intravenous Form Of Relenza Helped Save Life Of Swine-Flu Infected Woman Who Had Just Had Chemotherapy
- Anticancer Compound Found In American Mayapple
Random Posts
- Robotic Surgery Expert Dr. David B. Samadi Discusses The Benefits Of Surgery For Organ Confined Prostate Cancer
- Unprecedented Use Of DDT Concerns Experts
- Health Economics Model Shows Cervarix(R) Cross-Protective Efficacy Could Provide Greater Cost Reductions Than Protection Against Genital Warts
- ASH: Some Cancer Patients Get VTE Benefit from LMWH (CME/CE)
- UT Southwestern Childhood-cancer Survivor Program Celebrates 20 Years
- GlaxoSmithKline Withdraws Its Marketing Authorisation Application For Zunrisa (casopitant Mesilate)
- SABCS: Estrogen Again Implicated in Lung CA Prognosis (CME/CE)
- Studies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other Solid Malignancies
- Breast Cancer Risk Factors Vary by Tumor Subtype (CME/CE)
- Scientists From Applied Biosystems First To Sequence Entire Human Genome In Single Run At 17-fold Coverage
Prescription Cancer Drugs
Green Tea May Slow Prostate Cancer (CME/CE)
Posted by: admin in Prescription Cancer Drugs on August 22nd, 2009
LITTLE FALLS, N.J., June 19 — Certain compounds in green tea may slow the progression of prostate cancer, researchers say.
Men with prostate cancer who consumed polyphenon E — a polyphenol found in green tea — had a significant reduction in biomarkers of cancer progression, James A. Cardelli, PhD, of Louisiana State University, and colleagues reported in the July issue of Cancer Prevention Research.
“These findings support a potential role for polyphenon E in the treatment or prevention of prostate cancer,” the researchers said.
Some studies have shown that green tea may be tied to a reduced incidence of prostate cancer, and its polyphenols have been regarded as a potential cancer therapy.
- Explain that men in a small phase II study who consumed a polyphenol found in green tea had a significant reduction in biomarkers of cancer progression, including VEGF and HGF.
But epidemiological data on green tea consumption are still inconclusive: some studies show possible benefits and others find no effects on risk ratios for cancer, the researchers said.
Last year said FDA announced that the evidence for green tea benefits was inconclusive, because people consume relatively small quantities.
So the researchers conducted an open-label, single-arm phase II clinical trial to determine the effects of short-term supplementation with active compounds in green tea on serum biomarkers in patients with prostate cancer.
The biomarkers included hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), and prostate specific antigen (PSA).
They assessed 26 men, ages 41 to 68, who had been diagnosed with prostate cancer and were scheduled for radical prostatectomy.
The men consumed four capsules containing polyphenon E every day until the day before surgery. Four capsules are equivalent to about 12 cups of green tea, the researchers said.
They found a significant reduction in serum levels of the three biomarkers (P<0.03).
A total of 10 of 25 patients had more than a 25% decrease in HGF levels, and six of 25 had a greater than 25% decrease in their VEGF levels.
The researchers said that in vitro, EGCG (the main catechin in polyphenon E) rapidly blocked the production of HGF, and the block “seems to be at the level of transcription.”
EGCG also blocked the production of VEGF, which plays a critical role in the angiogenic process in cancer-associated fibroblasts, they said.
And age, race, and time on drug did not have a significant effect on the changes in serum biomarkers.
Some case studies have suggested that high doses of EGCG may have adverse effects on liver function.
But this study found that all markers of liver dysfunction decreased, five of them significantly: total protein, albumin, aspartate aminotransferase, alkaline phosphatase, and amylase.
“The doses that we used seem to be safe,” Dr. Cardelli said.
This raises a strictly practical question. The patients got results from taking concentrated active ingredients equal to 12 cups of tea daily.
“Does that translate to ‘If I drink 12 cups of green tea a day, will that work?’” Dr. Cardelli asked. “You can speculate, but I don’t know.”
Still, the researchers concluded that the data “support a potential role for polyphenon E in the treatment or prevention of prostate cancer.”
They said that the findings need to be “verified by larger, placebo-controlled clinical trials. The effects of different doses, long-term administration, and combination with other drugs remain to be seen.”
| Polyphenon Pharma supplied the polyphenon E used in the trial.
The researchers reported no conflicts of interest. |
Primary source: Cancer Prevention Research
Source reference:
McLarty J, et al “Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro” Cancer Prev Res 2009; 2(7).
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.
| Copyright 2009 |online pharmacy ambien no prescription buy xanax online no prescription online tramadol buying xanax online buy soma





